Spectrum Pharmaceuticals
| Company type | Public |
|---|---|
| Industry | Pharmaceuticals |
| Headquarters | Boston, Massachusetts, U.S. |
Key people | Tom Riga (CEO) |
| Revenue | US$109.33 million (2018) |
| Owner |
|
Number of employees | 164 (December 31, 2021) |
| Website | sppirx |
Spectrum Pharmaceuticals, Inc. is an American biopharmaceutical company located in Boston, MA. It develops and markets drugs for treatments in hematology and oncology.
After a deal valued at $248 million was announced in April 2023, Assertio Holdings announced that it had completed its acquisition of the Massachusetts-based company on July 31.